Biography of Robert Hofmeister
Last update: March 18, 2024Career
Robert was Chief Scientific Officer at TCR2 Therapeutics, and Vice President, ImmunoOncology at EMD Serono. Robert Hofmeister joined Alaunos Therapeutics in 2024.
Robert Hofmeister is currently- Chief Scientific Officer at Myeloid Therapeutics - View - Myeloid Therapeutics org chart
- Director at Alaunos Therapeutics - View - Alaunos Therapeutics org chart
Create your alert
to follow the career of Robert Hofmeister.
Education
Robert Hofmeister has a PhD in Immunology from University of Regensburg.
They have also studied at University of Regensburg :
Find more alumni from University of Regensburg
More about Robert Hofmeister
Selected links
Do you need to know more about Robert Hofmeister? More results.
Participate
Social media
- Robert Hofmeister on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Robert Hofmeister
The colleagues of Robert Hofmeister
Company Colleagues
- At Myeloid Therapeutics, Robert Hofmeister has 14 colleagues including Daniel Getts (CEO & Director), Brett Kaplan (Director)…
- At Alaunos Therapeutics, Robert Hofmeister has 5 colleagues including Kevin Boyle (CEO & Director), Holger Weis (Director)…
Industry Colleagues
- In the Pharmaceuticals industry, Robert Hofmeister has 19,344 colleagues in 1,862 companies located in 69 countries. 8,460 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.
Report an error
Update the org chart details of Robert Hofmeister.
Get in Touch
and ask for Robert Hofmeister.
